ORR for BI-1808 combined with pembrolizumab represents a meaningful improvement over pembrolizumab monotherapy in recurrent ovarian cancer (8% ORR in KEYNOTE-100)The combination demonstrated a ...
Pfizer Inc. today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, ...
Whether you're Apple Martin or Lila Moss, the career path for a nepo baby can be both gilded and predictable. But what about ...
Men, Magneto, supervillain and CEO of the Brotherhood of Evil Mutants, wants to destroy humanity – and in the first X-Men ...
KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...
News-Medical.Net on MSN
UH pharmacology professor wins $900,000 grant to develop a dual-function nanodrug for cancer
Accelerating advancements in cancer prevention and cures, Wei Gao, assistant professor of pharmacology at the University of Houston College of Pharmacy, has received a $900,000 grant from the Cancer ...
Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...
Why does cancer sometimes recur even after successful treatment, or why do some bacteria survive despite the use of powerful ...
Share on Pinterest Cannabis derivatives may lead to new treatments for ovarian cancer. Image Credit: Bloomberg Creative Photos/Getty Images Early lab research shows that two cannabis compounds, THC ...
The PAAG regimen significantly improved PFS and response rates in metastatic pancreatic cancer compared to chemotherapy alone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback